Published in J Hepatol on July 02, 2008
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer (2010) 1.25
Update on primary biliary cirrhosis. Dig Liver Dis (2010) 1.08
Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays. Mol Cell Proteomics (2012) 0.96
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol (2009) 0.91
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol (2009) 0.91
Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. PLoS One (2012) 0.91
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics (2011) 0.90
Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol (2010) 0.89
Natural killer cells regulate T cell immune responses in primary biliary cirrhosis. Hepatology (2015) 0.86
Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients. World J Gastroenterol (2010) 0.80
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights (2011) 0.79
Immune-mediated bile duct injury: The case of primary biliary cirrhosis. World J Gastrointest Pathophysiol (2010) 0.76
High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. PLoS One (2014) 0.76
Perforin expression in peripheral blood lymphatic cells of patients subjected to laparoscopic or open cholecystectomy. Mediators Inflamm (2009) 0.75
Autoimmunity in primary biliary cirrhosis: An alternative view at initiation and function of anti-mitochondrial autoantibodies. J Hepatol (2008) 0.75
Association study designs for complex diseases. Nat Rev Genet (2001) 8.91
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Primary biliary cirrhosis. Medicine (Baltimore) (1950) 7.07
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet (1965) 6.41
Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology (1959) 4.81
Prognosis in primary biliary cirrhosis: model for decision making. Hepatology (1989) 3.83
Primary biliary cirrhosis. N Engl J Med (1996) 3.51
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (2005) 2.91
Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol (1987) 2.90
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Regulation of the immune system by sex steroids. Endocr Rev (1984) 2.55
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol (1999) 2.19
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology (2005) 2.17
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology (2006) 1.96
Turner's syndrome. Lancet (2001) 1.94
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol (2000) 1.73
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl (2007) 1.69
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol (2004) 1.65
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med (1995) 1.61
Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology (2000) 1.55
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest (1998) 1.52
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev (2000) 1.50
Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology (1984) 1.49
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol (2006) 1.47
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol (1997) 1.42
X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol (2005) 1.41
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun (2006) 1.41
Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am J Hum Genet (1995) 1.41
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology (2007) 1.39
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun (2007) 1.36
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology (2006) 1.33
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut (2004) 1.31
Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol (2001) 1.28
Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology (2001) 1.27
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol (2001) 1.24
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology (2007) 1.23
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol (2003) 1.21
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology (1997) 1.20
Quality of life in patients with primary biliary cirrhosis. Hepatology (2004) 1.20
Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun (2006) 1.17
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut (2005) 1.17
Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology (2000) 1.17
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology (2006) 1.15
Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol (2007) 1.12
Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun (2007) 1.12
HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut (2001) 1.11
Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis (2005) 1.10
Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis (2005) 1.10
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology (2007) 1.10
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis (2004) 1.09
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun (2007) 1.07
The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet (1999) 1.05
Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol (2004) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
The immunological milieu of the liver. Semin Liver Dis (2007) 1.03
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03
Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology (2008) 1.03
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol (2005) 1.03
Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol (2000) 1.01
Characterization of antimitochondrial antibodies in health adults. Hepatology (1998) 1.01
Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut (1995) 0.98
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol (2003) 0.97
Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun (2005) 0.96
Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev (2002) 0.96
X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci (2007) 0.95
Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology (1989) 0.95
Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin Dev Immunol (2004) 0.92
Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun (2007) 0.90
Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. J Med Microbiol (2003) 0.88
Geographic clusters of primary biliary cirrhosis. Clin Dev Immunol (2004) 0.88
Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun (1998) 0.87
Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2005) 0.86
Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum Reprod (2000) 0.86
The association between gravidity and primary biliary cirrhosis. Ann Epidemiol (2002) 0.84
Murine models of primary biliary cirrhosis: Comparisons and contrasts. Hepatol Res (2007) 0.84
The X chromosome in female-predominant autoimmune diseases. Ann N Y Acad Sci (2007) 0.83
Primary biliary cirrhosis: does X mark the spot? Autoimmun Rev (2004) 0.82
T cell immunity and primary biliary cirrhosis. Autoimmun Rev (2003) 0.81
Primary biliary cirrhosis: for want of an X chromosome? Lancet (2004) 0.80
Update on primary biliary cirrhosis. Can J Gastroenterol (2000) 0.80
Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology (2007) 0.80
How, why, and when does primary biliary cirrhosis recur after liver transplantation? Liver Transpl (2007) 0.79
TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol (1999) 0.79
Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol (2004) 0.77
Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation. Clin Liver Dis (1998) 0.77
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Primary biliary cirrhosis. Hepatology (2009) 5.35
Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum (2002) 3.30
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology (2002) 2.18
Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology (2005) 2.17
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology (2007) 1.93
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Probiotics and immunity. J Gastroenterol (2009) 1.79
Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology (2013) 1.78
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (2015) 1.70
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology (2004) 1.67
Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology (2009) 1.65
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology (2009) 1.61
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol (2013) 1.57
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev (2009) 1.57
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol (2004) 1.57
Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev (2005) 1.57
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol (2003) 1.53
Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol (2003) 1.53
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
The SAPHO syndrome. Semin Arthritis Rheum (2012) 1.50
Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev (2004) 1.50
Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev (2005) 1.48
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology (2010) 1.47
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol (2005) 1.47
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology (2008) 1.45
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol (2005) 1.41
Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun (2009) 1.41
A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. J Med Food (2014) 1.41
The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol (2013) 1.41
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun (2006) 1.41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40
The retroviral myth of primary biliary cirrhosis: is this (finally) the end of the story? J Hepatol (2009) 1.39
Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis. Am J Gastroenterol (2004) 1.39
Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability. Clin Neurophysiol (2010) 1.39
Primary biliary cirrhosis. Lancet (2011) 1.37
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun (2007) 1.36
Lupus nephritis: a critical review. Autoimmun Rev (2012) 1.36
Is autoimmunity a matter of sex? Autoimmun Rev (2008) 1.35
Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology (2009) 1.34
Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev (2008) 1.33
Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology (2013) 1.33
Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev (2010) 1.33
Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) (2004) 1.32
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32
Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology (2008) 1.30
The implications of autoimmunity and pregnancy. J Autoimmun (2009) 1.28
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev (2012) 1.26
The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun (2008) 1.25
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol (2009) 1.25
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
The X chromosome and immune associated genes. J Autoimmun (2011) 1.24
Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun (2009) 1.24
The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun (2008) 1.24
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology (2007) 1.23
Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev (2004) 1.22
From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2005) 1.22
The immunobiology of systemic sclerosis. Semin Arthritis Rheum (2008) 1.22
Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs (2006) 1.21
Clinical significance of complement deficiencies. Ann N Y Acad Sci (2009) 1.21
Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB. J Biol Chem (2013) 1.21
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol (2003) 1.21
Drugs and autoimmunity--a contemporary review and mechanistic approach. J Autoimmun (2009) 1.21
Definition of human autoimmunity--autoantibodies versus autoimmune disease. Autoimmun Rev (2009) 1.20
Regulatory NK cells in autoimmune disease. J Autoimmun (2012) 1.19
Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol (2008) 1.19
Genetic and immunologic considerations in autism. Neurobiol Dis (2002) 1.19
Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis. Clin Rev Allergy Immunol (2011) 1.19
Juvenile idiopathic arthritis. Autoimmun Rev (2005) 1.18
Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology (2010) 1.18
Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun (2006) 1.17
The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol (2013) 1.17
Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology (2012) 1.17
B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology (2008) 1.17
Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun (2012) 1.16
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology (2006) 1.15